Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Valent

Showing results (501-510 of 662) with videos related to

Pageof 67
Sort By:
Blood|July 19, 2018
CD44 is a RAS/STAT5-regulated invasion receptor that triggers disease expansion in advanced mastocytosisNiklas Mueller, Daniel Wicklein, Gregor Eisenwort, et al.
Cancers|July 9, 2022
CDK4/CDK6 Inhibitors Synergize with Midostaurin, Avapritinib, and Nintedanib in Inducing Growth Inhibition in <i>KIT</i> D816V<sup>+</sup> Neoplastic Mast CellsMathias Schneeweiss-Gleixner, Yüksel Filik, Gabriele Stefanzl, et al.
Advances in Immunology|May 8, 2018
Molecular Aspects of Allergens and AllergyRudolf Valenta, Alexander Karaulov, Verena Niederberger, et al.
The New England Journal of Medicine|June 30, 2016
Efficacy and Safety of Midostaurin in Advanced Systemic MastocytosisJason Gotlib, Hanneke C Kluin-Nelemans, Tracy I George, et al.
Hemasphere|May 14, 2026
CDK6 inactivation counteracts CALR-mutant-induced MPN evolution and sensitizes MPN stem cells to interferon-α treatmentBrian Ringhofer, Wolfram Polzer, Michaela Prchal-Murphy, et al.
International Journal of Molecular Sciences|April 3, 2021
Molecular Background, Clinical Features and Management of Pediatric Mastocytosis: Status 2021Magdalena Lange, Karin Hartmann, Melody C Carter, et al.
Haematologica|April 24, 2025
Changes in cardiac parameters during venetoclax treatmentRoman Brock, Edit Porpaczy, Patrick Caron, et al.
Leukemia Research|February 14, 2014
Azacitidine in CMML: matched-pair analyses of daily-life patients reveal modest effects on clinical course and survivalLisa Pleyer, Ulrich Germing, Wolfgang R Sperr, et al.
Genes, Chromosomes & Cancer|January 18, 2018
Incidence and prognostic impact of cytogenetic aberrations in patients with systemic mastocytosisNicole Naumann, Mohamad Jawhar, Juliana Schwaab, et al.
American Journal of Hematology|July 7, 2022
BRD4 degradation blocks expression of MYC and multiple forms of stem cell resistance in Ph<sup>+</sup> chronic myeloid leukemiaBarbara Peter, Gregor Eisenwort, Irina Sadovnik, et al.
Pageof 67

Showing results (501-510 of 662) with videos related to

Sort By:
Pageof 67
Blood|July 19, 2018
CD44 is a RAS/STAT5-regulated invasion receptor that triggers disease expansion in advanced mastocytosisNiklas Mueller, Daniel Wicklein, Gregor Eisenwort, et al.
Cancers|July 9, 2022
CDK4/CDK6 Inhibitors Synergize with Midostaurin, Avapritinib, and Nintedanib in Inducing Growth Inhibition in <i>KIT</i> D816V<sup>+</sup> Neoplastic Mast CellsMathias Schneeweiss-Gleixner, Yüksel Filik, Gabriele Stefanzl, et al.
Advances in Immunology|May 8, 2018
Molecular Aspects of Allergens and AllergyRudolf Valenta, Alexander Karaulov, Verena Niederberger, et al.
The New England Journal of Medicine|June 30, 2016
Efficacy and Safety of Midostaurin in Advanced Systemic MastocytosisJason Gotlib, Hanneke C Kluin-Nelemans, Tracy I George, et al.
Hemasphere|May 14, 2026
CDK6 inactivation counteracts CALR-mutant-induced MPN evolution and sensitizes MPN stem cells to interferon-α treatmentBrian Ringhofer, Wolfram Polzer, Michaela Prchal-Murphy, et al.
International Journal of Molecular Sciences|April 3, 2021
Molecular Background, Clinical Features and Management of Pediatric Mastocytosis: Status 2021Magdalena Lange, Karin Hartmann, Melody C Carter, et al.
Haematologica|April 24, 2025
Changes in cardiac parameters during venetoclax treatmentRoman Brock, Edit Porpaczy, Patrick Caron, et al.
Leukemia Research|February 14, 2014
Azacitidine in CMML: matched-pair analyses of daily-life patients reveal modest effects on clinical course and survivalLisa Pleyer, Ulrich Germing, Wolfgang R Sperr, et al.
Genes, Chromosomes & Cancer|January 18, 2018
Incidence and prognostic impact of cytogenetic aberrations in patients with systemic mastocytosisNicole Naumann, Mohamad Jawhar, Juliana Schwaab, et al.
American Journal of Hematology|July 7, 2022
BRD4 degradation blocks expression of MYC and multiple forms of stem cell resistance in Ph<sup>+</sup> chronic myeloid leukemiaBarbara Peter, Gregor Eisenwort, Irina Sadovnik, et al.
Pageof 67